Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 12.42
(2.14%)
CNY 12.42
(2.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 618.29 Million CNY | 22.18% |
| 2022 | 506.03 Million CNY | 6.73% |
| 2021 | 474.13 Million CNY | 3.18% |
| 2020 | 459.53 Million CNY | 28.95% |
| 2019 | 356.35 Million CNY | 18.67% |
| 2018 | 300.29 Million CNY | -1.19% |
| 2017 | 303.9 Million CNY | 14.7% |
| 2016 | 264.94 Million CNY | 20.75% |
| 2015 | 219.42 Million CNY | -3.41% |
| 2014 | 227.18 Million CNY | 4.57% |
| 2013 | 217.24 Million CNY | -15.07% |
| 2012 | 255.79 Million CNY | 23.72% |
| 2011 | 206.74 Million CNY | 16.35% |
| 2010 | 177.69 Million CNY | 18.63% |
| 2009 | 149.79 Million CNY | 6.68% |
| 2008 | 140.4 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 137.1 Million CNY | 26.55% |
| 2024 Q1 | 154.29 Million CNY | -3.17% |
| 2024 Q2 | 108.34 Million CNY | -29.78% |
| 2023 Q2 | 159.44 Million CNY | 1.0% |
| 2023 Q3 | 141.65 Million CNY | -11.16% |
| 2023 Q4 | 159.33 Million CNY | 12.48% |
| 2023 FY | 618.29 Million CNY | 22.18% |
| 2023 Q1 | 157.86 Million CNY | 1.03% |
| 2022 Q1 | 97.71 Million CNY | -34.12% |
| 2022 Q4 | 156.24 Million CNY | 10.99% |
| 2022 Q2 | 111.29 Million CNY | 13.89% |
| 2022 Q3 | 140.77 Million CNY | 26.5% |
| 2022 FY | 506.03 Million CNY | 6.73% |
| 2021 Q3 | 123.5 Million CNY | 15.15% |
| 2021 Q4 | 148.32 Million CNY | 20.09% |
| 2021 Q1 | 95.03 Million CNY | -33.48% |
| 2021 FY | 474.13 Million CNY | 3.18% |
| 2021 Q2 | 107.26 Million CNY | 12.86% |
| 2020 FY | 459.53 Million CNY | 28.95% |
| 2020 Q3 | 136.73 Million CNY | 32.6% |
| 2020 Q2 | 103.11 Million CNY | 34.23% |
| 2020 Q4 | 142.86 Million CNY | 4.48% |
| 2020 Q1 | 76.81 Million CNY | -35.83% |
| 2019 Q2 | 70.27 Million CNY | 4.06% |
| 2019 Q4 | 119.71 Million CNY | 21.14% |
| 2019 FY | 356.35 Million CNY | 18.67% |
| 2019 Q1 | 67.53 Million CNY | -35.5% |
| 2019 Q3 | 98.82 Million CNY | 40.61% |
| 2018 Q4 | 104.71 Million CNY | 54.35% |
| 2018 FY | 300.29 Million CNY | -1.19% |
| 2018 Q2 | 60.15 Million CNY | -11.0% |
| 2018 Q1 | 67.58 Million CNY | -25.95% |
| 2018 Q3 | 67.84 Million CNY | 12.78% |
| 2017 Q3 | 70.73 Million CNY | 7.65% |
| 2017 Q4 | 91.27 Million CNY | 29.04% |
| 2017 Q2 | 65.7 Million CNY | -13.76% |
| 2017 FY | 303.9 Million CNY | 14.7% |
| 2017 Q1 | 76.19 Million CNY | -15.89% |
| 2016 FY | 264.94 Million CNY | 20.75% |
| 2016 Q2 | 48.96 Million CNY | -21.49% |
| 2016 Q1 | 62.36 Million CNY | 0.25% |
| 2016 Q3 | 63.03 Million CNY | 28.75% |
| 2016 Q4 | 90.58 Million CNY | 43.7% |
| 2015 Q2 | 47.28 Million CNY | -22.54% |
| 2015 FY | 219.42 Million CNY | -3.41% |
| 2015 Q4 | 62.2 Million CNY | 27.26% |
| 2015 Q1 | 61.05 Million CNY | -9.58% |
| 2015 Q3 | 48.88 Million CNY | 3.36% |
| 2014 Q4 | 67.51 Million CNY | 43.3% |
| 2014 Q2 | 54.01 Million CNY | -7.71% |
| 2014 Q1 | 58.52 Million CNY | -12.59% |
| 2014 FY | 227.18 Million CNY | 4.57% |
| 2014 Q3 | 47.11 Million CNY | -12.77% |
| 2013 Q3 | 38.79 Million CNY | -13.74% |
| 2013 Q1 | 66.51 Million CNY | -16.35% |
| 2013 FY | 217.24 Million CNY | -15.07% |
| 2013 Q4 | 66.96 Million CNY | 72.6% |
| 2013 Q2 | 44.97 Million CNY | -32.39% |
| 2012 FY | 255.79 Million CNY | 23.72% |
| 2012 Q4 | 79.51 Million CNY | 36.82% |
| 2012 Q3 | 58.11 Million CNY | 11.98% |
| 2012 Q2 | 51.9 Million CNY | -21.66% |
| 2012 Q1 | 66.25 Million CNY | 1.71% |
| 2011 Q1 | 47.16 Million CNY | 0.0% |
| 2011 FY | 206.74 Million CNY | 16.35% |
| 2011 Q2 | 44.43 Million CNY | -5.78% |
| 2011 Q3 | 49.99 Million CNY | 12.5% |
| 2011 Q4 | 65.13 Million CNY | 30.29% |
| 2010 FY | 177.69 Million CNY | 18.63% |
| 2009 FY | 149.79 Million CNY | 6.68% |
| 2008 FY | 140.4 Million CNY | 0.0% |